On-Demand Downstream Manufacturing Webinars

  1. Navigating Downstream Bioprocessing For Biosimilar Development 3/31/2025

    Unlock efficient biosimilar production with expert insights that reveal how advanced purification technologies can significantly reduce costs and meet stringent regulatory demands in today's market.

  2. Tools For Efficient Downstream Processing Of Antibody-Based Therapeutics 3/20/2025

    Watch and discover how to effectively utilize chromatography tools for improved purification of therapeutic monoclonal antibodies and antibody derivatives.

  3. Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective 2/18/2025

    Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.

  4. Scalable Expansion And Downstream Processing Of High-Quality hiPSCs 1/31/2025

    Learn about a scalable, microcarrier-based 3D culture process for expanding hiPSCs to 10L, yielding over 10 billion cells while maintaining quality.

  5. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

    Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.

  6. mAb Up- And Downstream Process Intensification Strategies 12/12/2024

    Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.

  7. Robust Process Solutions To Purify GLP-1 Receptor Agonists 10/31/2024

    Watch to learn how to optimize GLP-1 production, how throughput and performance affect downstream processes in protein therapies, and how to enhance yield and purity for optimal process outcomes.

  8. Multi-Tiered Classification For Downstream Process Intensification 10/31/2024

    Watch to learn about the various levels of intensification, core technologies used in the industry, and the impact of each level on productivity through a monoclonal antibody (mAb) platform.

  9. Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes 10/10/2024

    Watch to explore how to maximize AAV full capsid recovery, establish a scalable platform for various serotypes, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.

  10. Effective Strategies For Endotoxin Removal In Therapeutic Protein Purification 10/8/2024

    Endotoxins can cause major upheaval in downstream purification. Explore case studies using various resins that have been successfully used for endotoxin removal.